TPM4 and glioma: In recent years, the abnormal expression of TPM4 was investigated in multiple malignancies, invasive breast cancer (7), colon cancer (8), glioma (9), hepatocellular carcinoma (10), lung cancer (11), and ovarian cancer (12).